Quest Diagnostics Bought and Sold Labs in October
The Labs, MRI & Dialysis sector saw a surge of deal making in October. The sector is a conglomeration of various healthcare segments, obviously, but clinical laboratories drove the nine announced transactions. Quest Diagnostics Inc. (NYSE: DGX) announced three of those deals, first with its divestiture of its India-based medical diagnostics business, consisting of 24 diagnostic labs across the sub-continent, including a large specialized diagnostics practice with three reference labs with expertise in oncology, genomics and precision medicine. The buyer was Strand Life Sciences, a portfolio company of Quadria Capital, a clinical research and diagnostics company that combines... Read More »Reporter’s Notebook: PE Healthcare Investor Forum 2016
The first-ever Private Equity Healthcare Investor Forum took place in New York City on April 27, 2016 at the Westin Times Square. We were invited to attend by the sponsor, Private Equity International. The conference was originally planned to span two days, but was cut down to a single, panel-crammed event a few weeks before. Attendance was spotty, and at times it seemed the bulk of the audience were all speakers. Don’t get us wrong, we’d go again, if invited. The most interesting panel, in our opinion, was moderated by Richard Zall, partner and chair of Proskauer’s Health Care Department. Titled “When healthcare meets private equity: analyzing investor trends and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
